Table 4 Effect of atosiban in different cause of infertility on pregnancy outcomes.
From: Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles
Variable | Tubal factor | Endometriosis | Male factor | Other | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group A (n = 520) | Group B (n = 769) | P value | Group A (n = 45) | Group B (n = 88) | P value | Group A (n = 53) | Group B (n = 125) | P value | Group A (n = 59) | Group B (n = 115) | P value | |
Clinical pregnancy rate | 267/520 (51.3%) | 371/769 (48.2%) | 0.281 | 26/45 (57.8%) | 43/88 (48.9%) | 0.363 | 24/53 (45.3%) | 71/125 (56.8%) | 0.190 | 30/59 (50.8%) | 62/115 (53.9%) | 0.750 |
Clinical miscarriage rate | 58/267 (21.7%) | 65/371 (17.5%) | 0.188 | 6/26 (23.1%) | 11/43 (25.6%) | 1 | 5/724 (20.8%) | 19/71 (26.8%) | 0.786 | 9/30 (30.0%) | 12/62 (19.4%) | 0.294 |
Ectopic pregnancy rate | 1/267 (0.4%) | 3/371 (0.3%) | 0.644 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
Preterm birth rate | 16/520 (3.1%) | 27/769 (3.5%) | 0.753 | 1/45 (2.2%) | 6/88 (6.8%) | 0.422 | 2/53 (3.8%) | 8/125 (6.4%) | 0.725 | 1/59 (1.7%) | 5/115 (4.3%) | 0.665 |
Live birth rate | 209/520 (40.2%) | 301/769 (39.1%) | 0.728 | 20/45 (44.4%) | 31/88 (35.2%) | 0.348 | 19/53 (35.8%) | 51/125 (40.8%) | 0.616 | 21/59 (35.6%) | 45/115 (39.1%) | 0.742 |
